Skip to content
Screener

LB Pharmaceuticals Inc LBRX Q4 2025 Annual earnings

Reported March 26, 2026 · Before market open

EPS-$0.45In line
EPS estimate-$0.45

Next report

Nov 5, 2026 (in 2 months)
EPS estimate-$1.61

Financials

Q4 2025

Income statement

See full
Net income-$11.5M-126%

Balance sheet

See full
Cash & equivalents$250.2M+989%
Total debt$3.6M-3.6%
Total equity$301.3M+419%
Total assets$312.9M+833%

Cash flow

See full
Operating cash flow-$18.1M-220%
CapEx$40.0K-83.2%
Free cash flow-$18.1M-207%

Valuation & ratios

Valuation

as of 12/31/25
See full
Market cap$563.16M—
Enterprise value$316.55M—

Returns & leverage

See full
Debt / equity0×—
Current ratio41.4×+37.9×

FAQ

When did LB Pharmaceuticals Inc report Q4 2025 earnings?
LB Pharmaceuticals Inc (LBRX) reported Q4 2025 earnings on March 26, 2026 before market open.
What were LB Pharmaceuticals Inc's Q4 2025 revenue and EPS?
LB Pharmaceuticals Inc reported eps of $-0.45 for Q4 2025.
Did LB Pharmaceuticals Inc beat estimates in Q4 2025?
EPS beat the consensus estimate of $-0.45 by $0.00.
Where can I find LB Pharmaceuticals Inc's Q4 2025 SEC filings?
You can read the 8-K earnings release (0001193125-26-126223) and the 10-K periodic report (0001193125-26-126368) directly on SEC EDGAR. The filing index links above go to sec.gov.